homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

January 3, 2018

OncoResponse

In Seattle, OncoResponse added Anil Singhal, Ph.D., as chief scientific officer, and Kamal D. Puri, Ph.D., as vice president of research and development. Singhal comes from AbbVie, and Puri from Celgene. Houston-based OncoResponse develops therapeutic antibodies for cancer patients.




Email or user name:
Password:
 
Forgot password? Click here.